BackGiant Biogene Holding , Ltd. Overview

Giant Biogene Holding , Ltd. Receivables

Giant Biogene Holding , Ltd.'s receivables is $390M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$388.47M
↓ 16.72% YoYΔ $-78.01M vs prior year quarter

Peer trimmed avg / median

Loading

Giant Biogene Holding , Ltd. Receivables History

Loading

Giant Biogene Holding , Ltd. vs. peers: Receivables Comparison

Loading

Giant Biogene Holding , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Giant Biogene Holding , Ltd. (2367.HK) FAQ

As of the most recent data (June 2026), 2367.HK shows a receivables of $390M. That compares with $470M in the prior-year period — down 16.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 2367.HK's receivables is now $390M (was $470M) — a 16.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Giant Biogene Holding , Ltd. is outperforming or lagging.

Tracking 2367.HK's receivables over time shows whether Giant Biogene Holding , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $390M That compares with $470M in the prior-year period — down 16.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Giant Biogene Holding , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $390M) with ownership activity and broader fundamentals.

Questions & Answers